ab108642 Cancer Antigen CA19-9 Human ELISA Kit is intended for the quantitative determination of the Cancer Antigen CA19-9 concentration in Human serum.
A group of mucin type glycoprotein Sialosyl Lewis Antigens (SLA), such as CA19-9 and CA19-5, have come to be recognized as circulating cancer associated antigens for gastrointestinal cancer. Cancer Antigen CA19-9 represents the most important and basic carbohydrate tumor marker. The immunohistologic distribution of Cancer Antigen CA19-9 in tissues is consistent with the quantitative determination of higher CA19-9 concentrations in cancer than in normal or inflamed tissues. Recent reports indicate that the serum CA19-9 level is frequently elevated in the serum of subjects with various gastrointestinal malignancies, such as pancreatic, colorectal, gastric and hepatic carcinomas. Research studies demonstrate that serum CA19-9 values may have utility in monitoring subjects with the above-mentioned diagnosed malignancies. It has been shown that a persistent elevation in serum CA19-9 value following treatment may be indicative of occult metastatic and/or residual disease. A persistently rising serum Cancer Antigen CA19-9 value may be associated with progressive malignant disease and poor therapeutic response. A declining Cancer Antigen CA19-9 value may be indicative of a favorable prognosis and good response to treatment.
|Components||1 x 96 tests|
|20X Washing Solution||1 x 50ml|
|Assay Buffer||1 x 13ml|
|Cancer Antigen CA19-9 reference standard 1||1 x 0.5ml|
|Cancer Antigen CA19-9 reference standard 2||1 x 0.5µl|
|Cancer Antigen CA19-9 reference standard 3||1 x 0.5ml|
|Cancer Antigen CA19-9 reference standard 4||1 x 0.5ml|
|Cancer Antigen CA19-9 reference standard 5||1 x 0.5ml|
|Cancer Antigen CA19-9 reference standard 6||1 x 0.5ml|
|Enzyme Conjugate Concentrate||1 x 1.1ml|
|Enzyme Conjugate Diluent||1 x 13ml|
|Murine monoclonal anti-Cancer Antigen CA19-9 coated microtiter plate.||1 unit|
|Stop Solution||1 x 11ml|
|TMB Substrate Solution||1 x 11ml|
Our Abpromise guarantee covers the use of ab108642 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent dilution.|
ab108642 has not yet been referenced specifically in any publications.